2019-10-15

Press releases regulatory

2cureX continues its IP expansion by securing a patent on Its IndiTreat test in Hong Kong

2cureX AB (“2cureX”, NASDAQ: 2CUREX) is pleased to announce the granting of a Hong Kong patent (HK1237870) on its key...

2019-10-08

Press releases regulatory

2cureX has made an agreement with one of the largest private cancer hospitals in the Nordic countries

2cureX AB (“2cureX”, NASDAQ: 2CUREX) today announces that the company has established a commercial agreement with one of the largest...

2019-08-23

Press releases regulatory

2cureX publishes half-year report for the first half of 2019

2cureX AB (“2cureX”) hereby publishes the half-year report for the first half of 2019. The half-year report is available as...

2019-07-23

Press releases regulatory

2cureX announces that patients are successfully being enrolled in the IndiTreat® pancreatic cancer trial

2cureX AB (“2cureX”, NASDAQ: 2CUREX), a clinical-stage company that has developed the IndiTreat® test allowing individualization of cancer treatment, hereby...

2019-06-27

Press releases regulatory

Last day of trading in BTA 1 in 2cureX AB

In May 2019, 2cureX AB (“2cureX”) conducted a rights issue of shares in which the general public was given the...

2019-06-25

Press releasesPress releases regulatory

Change of Certified Adviser to Svensk Kapitalmarknadsgranskning AB

2cureX AB (“2cureX”) has entered into an agreement with Svensk Kapitalmarknadsgranskning AB (“SKMG”) regarding Certified Adviser services. SKMG will be...